欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0438/003
药品名称
bica Nova 4,25% Glucose
活性成分
calcium chloride 0.36 g
glucose 10.99 g
剂型
Solution for peritoneal dialysis
上市许可持有人
Fresenius Medical Care Deutschland GmbH Else-Kroener-Str. 1 D-61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Italy (IT)
许可日期
2005/07/26
最近更新日期
2021/11/10
药物ATC编码
B05DB Hypertonic solutions
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Bibliographic [Article 10.1(a)(ii)]
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final SPC
|
common-spc-bicanova15-201905-track
Date of last change:2019/08/19
Final SPC
|
common-spc-bicanova15-201905
Date of last change:2019/08/19
Final SPC
|
common-spc-bicanova425-201905
Date of last change:2019/08/19
Final SPC
|
common-spc-bicanova23-201905
Date of last change:2019/08/19
Final SPC
|
common-spc-bicanova23-201905-track
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova15-201905-track
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova23-201905
Date of last change:2019/08/19
Final SPC
|
common-spc-bicanova425-201905-track
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova15-201905
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova425-201905-track
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova23-201905-track
Date of last change:2019/08/19
Final PL
|
common-pl-bicanova425-201905
Date of last change:2019/08/19
Final Product Information
|
common-impack-bicanova15sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-impack-bicanova15sts-201508
Date of last change:2016/03/04
Final Product Information
|
common-impack-bicanova23sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-impack-bicanova23sts-201508
Date of last change:2016/03/04
Final Product Information
|
common-impack-bicanova425sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-impack-bicanova425sts-201508-rev
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova15sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova15sts-201508
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova23sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova23sts-201508-rev
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova425sls-201508
Date of last change:2016/03/04
Final Product Information
|
common-outer-bicanova425sts-201508-rev
Date of last change:2016/03/04
Final Product Information
|
common-pl-bicanova15-201508
Date of last change:2016/03/04
Final Product Information
|
common-pl-bicanova23-201508
Date of last change:2016/03/04
Final Product Information
|
common-pl-bicanova425-201508
Date of last change:2016/03/04
Final Product Information
|
common-spc-bicanova15-201508
Date of last change:2016/03/04
Final Product Information
|
common-spc-bicanova23-201508
Date of last change:2016/03/04
Final Product Information
|
common-spc-bicanova425-201508
Date of last change:2016/03/04
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase